Royalty Pharma plc 8-K

What Happened

• Royalty Pharma plc announced its financial results for the quarter ended March 31, 2026 in a press release dated May 6, 2026. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8-K filed on May 6, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Press release date: May 6, 2026.
• Reporting period: quarter ended March 31, 2026.
• Form 8-K Item: 2.02 (Results of Operations and Financial Condition); press release furnished as Exhibit 99.1.
• Exhibit 104: Cover Page Interactive Data File (Inline XBRL) was provided with the filing.

Why It Matters

• This 8-K provides Royalty Pharma’s latest quarterly results and is the primary source for the company’s reported earnings, revenue, and financial condition for the quarter ended March 31, 2026. Retail investors should review the furnished press release for specific metrics (revenue, net income, cash flow and any management commentary or guidance) and watch for follow-up filings or investor calls that may include more detailed financial statements or context.